Whistler Therapeutics is an organic certified cannabis researcher, producer, and processor. Using a patent-pending extraction and infusion method, we can retain terpenes from fresh cannabis in an active extract. This process uses only ice, water, and a hydrophobic nonvolatile carrier, creating an environmentally friendly and low-cost alternative to solvent extractions. The active extract is then formulated into an array of product types with standardized cannabinoid and terpene content, with terpene concentrations much higher than found in dry cannabis sativa inflorescence. Whistler Therapeutics was founded by Daniel Lantela and Brishna Kamal with the vision of creating sustainable cannabis-based pharmaceuticals through the integration of medical research and regenerative agriculture. Whistler Therapeutics is the sister company of Whistler Technologies; manufacturer of solvent-less extraction systems and was founded shortly after. Our company will be working closely with innovators to create new processes and premium, beyond full spectrum cannabis products for the Canadian and global markets.